We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

CRISM Therapeutics Corp (CRTX) NPV

Sell:9.00p Buy:10.00p 0 Change: No change
Market closed Prices as at close on 22 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:9.00p
Buy:10.00p
Change: No change
Market closed Prices as at close on 22 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:9.00p
Buy:10.00p
Change: No change
Market closed Prices as at close on 22 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

CRISM Therapeutics Corporation, formerly Amur Minerals Corporation, is a British Virgin Islands-based pharmaceutical company. The Company has developed a drug delivery technology, ChemoSeed, to improve the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy. Its lead product, ChemoSeed, is a polymer the size of a grain of rice, administering irinotecan, a generic drug approved to treat brain cancer and can be implanted directly into a tumor or the resection margin following the removal of a tumor, thereby ensuring that effective therapeutic concentrations of chemotherapy drugs directly reach the tumor tissue. It seeks to use ChemoSeed to treat high grade gliomas, a brain tumor with no satisfactory treatment. The Company also offers formulation and consultancy services. It provides assistance and services to improve the bioavailability of poorly soluble drugs. It offers remixers and extruders of various sizes.

Contact details

Address:
Kingston Chambers,, Road Town
PO Box 173
TORTOLA
680063
Virgin Islands (British)
Telephone:
+7 (0421) 2755615
Website:
https://www.crismtherapeutics.com/

Important dates

Future events
There are no future events available.
Past events
Interim results 19 September 2024 19/09/24
General meeting 29 May 2024 29/05/24
AGM 29 May 2024 29/05/24
Final results 10 May 2024 10/05/24

General stock information

EPIC:
CRTX
ISIN:
VGG042401262
Market cap:
£3.10 million
Shares in issue:
32.68 million
Sector:
No specific Industry
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Robin Young
    Chief Executive Officer, Executive Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.